- Home
- MGIC vs GALT Comparison
MGIC vs GALT Comparison
Compare MGIC & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- GALT
- Stock Information
- Founded
- MGIC 1983
- GALT 2000
- Country
- MGIC Israel
- GALT United States
- Employees
- MGIC N/A
- GALT N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- GALT Health Care
- Exchange
- MGIC Nasdaq
- GALT Nasdaq
- Market Cap
- MGIC 788.0M
- GALT 83.5M
- IPO Year
- MGIC 1991
- GALT N/A
- Fundamental
- Price
- MGIC $21.34
- GALT $2.23
- Analyst Decision
- MGIC Buy
- GALT Buy
- Analyst Count
- MGIC 2
- GALT 2
- Target Price
- MGIC $16.00
- GALT $6.00
- AVG Volume (30 Days)
- MGIC 76.1K
- GALT 1.5M
- Earning Date
- MGIC 08-13-2025
- GALT 08-12-2025
- Dividend Yield
- MGIC 2.77%
- GALT N/A
- EPS Growth
- MGIC 1.33
- GALT N/A
- EPS
- MGIC 0.76
- GALT N/A
- Revenue
- MGIC $569,136,000.00
- GALT N/A
- Revenue This Year
- MGIC $7.53
- GALT N/A
- Revenue Next Year
- MGIC $8.96
- GALT N/A
- P/E Ratio
- MGIC $27.61
- GALT N/A
- Revenue Growth
- MGIC 6.37
- GALT N/A
- 52 Week Low
- MGIC $9.64
- GALT $0.73
- 52 Week High
- MGIC $21.98
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- MGIC 80.60
- GALT 57.12
- Support Level
- MGIC $20.17
- GALT $2.07
- Resistance Level
- MGIC $21.98
- GALT $2.36
- Average True Range (ATR)
- MGIC 0.52
- GALT 0.45
- MACD
- MGIC 0.29
- GALT -0.04
- Stochastic Oscillator
- MGIC 88.01
- GALT 18.54
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.